Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Compassion training shows promise for racism stress relief

NCT ID NCT06146218

Symptom relief Sponsor: Rockefeller University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested a 10-week compassion-based resiliency training (CBRT) program in 22 African American adults to see if it could help reduce stress from racism. The program taught mindfulness, self-awareness, and stress-reduction techniques. Researchers measured stress, mood, sleep, and biological markers like cortisol and gene expression. The goal was to see if the program was feasible and acceptable, and if it showed early signs of helping with psychological well-being.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

22 people

The number who actually took part.

Started

Feb 2024

Finished

Aug 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Self Identity as African American or Black * 18-50 years old * Fluent in English Exclusion Criteria: * History of significant pre-existing brain disease or injury (e.g., dementia, stroke, seizure disorder, and head injury with cognitive sequelae or loss of consciousness more than 30 minutes, seizure disorder) * Reported history of learning disability/mental retardation * Current Attention Deficit Hyperactive Disorder (ADHD), depression, bipolar disorder, post-traumatic stress disorder (PTSD), or psychotic disorder diagnosis * Current psychotropic medication (as these medications are known impacts on brain function) e.g. antipsychotics, antianxiety * Severe/chronic medical illness (e.g., reported HIV+ status, cardiovascular disease, liver disease/cirrhosis, chronic kidney disease, current/past cancer with radiation/chemotherapy treatment, etc.) * Current methadone/suboxone/buprenorphine (or similar) maintenance * Use of illicit substances other than cannabis within the past 90 days * Pregnant * Major life events in the last 30 days (hospitalization, marriage, death in the family of friends, disaster)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RACISM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Racism Stress, Psychological

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RACISM Stress, psychological

Contacts and locations

Locations

  • Recrutment Office

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.